– Fleites YA, Aguiar J, Cinza Z, Bequet M, Marrero E, Vizcaíno M, et al. HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis. Euroasian J Hepatogastroenterol. 2021 Jul-Dec;11(2):59–70.
– Guinovart-Sanjuán D, Guinovart-Díaz R, Vajravelu K, Morales-Lezca W, Abelló-Ugalde I. Multi-population analysis of the Cuban SARS-CoV-2 epidemic transmission before and during the vaccination process. Phys Fluids. 2021 Oct;33(10):107107.
– Lobaina Y, Urquiza D, Garay H, Perera Y, Yang K. Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination. Int J Pept Res Ther. 2021 Oct 13:1–10.
– Rodríguez-Rodríguez N, Martínez-Jiménez I, García-Ojalvo A, Mendoza-Marí Y, Guillén-Nieto G, Armstrong DG, et al. Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients. MEDICC Review, 2021; https://doi.org/10.37757/MR2021.V23.N3.8.
En la sección: Autores cubanos en revistas extranjeras, COVID-19, Inmunidad de mucosas, Vacunología. Publicado en: . 
